{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:01:23Z","timestamp":1776949283240,"version":"3.51.4"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.3201\/eid2701.201178","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T23:51:32Z","timestamp":1608594692000},"page":"150-160","source":"Crossref","is-referenced-by-count":24,"title":["Post\u201313-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines"],"prefix":"10.3201","volume":"27","author":[{"given":"Shalom","family":"Ben-Shimol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noga","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leore","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Adriaan van der Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2701.201178-202012202036-R1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"key-10.3201\/eid2701.201178-202012202036-R2","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"key-10.3201\/eid2701.201178-202012202036-R3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/MMBR.65.2.187-207.2001","article-title":"Pneumococcal virulence factors: structure and function.","volume":"65","author":"Jedrzejas","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"key-10.3201\/eid2701.201178-202012202036-R4","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.vaccine.2003.11.038","article-title":"Pneumococcal vaccines: an update on current strategies.","volume":"22","author":"Bogaert","year":"2004","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R5","doi-asserted-by":"publisher","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2701.201178-202012202036-R6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/cid\/ciz768","article-title":"Use of chest radiography examination as a probe for pneumococcal conjugate vaccine impact on lower respiratory tract infections in young children.","volume":"71","author":"Ben-Shimol","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R7","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent\/13-valent PCV.","volume":"59","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R8","doi-asserted-by":"publisher","first-page":"e0166736","DOI":"10.1371\/journal.pone.0166736","article-title":"Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review.","volume":"11","author":"de Oliveira","year":"2016","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2701.201178-202012202036-R9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.","volume":"12","author":"Ben-Shimol","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2701.201178-202012202036-R10","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","article-title":"Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.","volume":"37","author":"Thompson","year":"2019","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/21645515.2019.1568159","article-title":"A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.","volume":"15","author":"Rupp","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2701.201178-202012202036-R12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2018.11.054","article-title":"Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis.","volume":"37","author":"Ben-Shimol","year":"2019","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/cid\/ciw347","article-title":"Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media.","volume":"63","author":"Ben-Shimol","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R14","doi-asserted-by":"crossref","unstructured":"Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S,  Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: An active prospective nationwide surveillance. Vaccine. 2014;32:3452\u20139.10","DOI":"10.1016\/j.vaccine.2014.03.065"},{"key":"key-10.3201\/eid2701.201178-202012202036-R15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/01.inf.0000178066.24569.98","article-title":"Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era.","volume":"24","author":"Buznach","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2701.201178-202012202036-R16","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1016\/j.vaccine.2012.08.012","article-title":"Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.","volume":"30","author":"Ben-Shimol","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R17","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 28th edition informational supplement (M100-S28). Wayne (PA): The Institute; 2018."},{"key":"key-10.3201\/eid2701.201178-202012202036-R18","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination.","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"key-10.3201\/eid2701.201178-202012202036-R19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/cid\/ciy726","article-title":"Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of nonvaccine serotypes among vaccinated infants and their mothers 5 years after introduction of pneumococcal conjugate vaccine 13 in The Gambia.","volume":"68","author":"Usuf","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/cid\/ciy926","article-title":"Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccine implementation in young children.","volume":"69","author":"Danino","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R21","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1128\/AAC.03344-14","article-title":"Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2701.201178-202012202036-R22","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","article-title":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.","volume":"33","author":"Varon","year":"2015","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jinf.2019.10.009","article-title":"Outbreaks of severe pneumococcal disease in closed settings in the conjugate vaccines era, 2010-2018: A systematic review to inform national guidance in the UK.","volume":"79","author":"Amin-Chowdhury","year":"2019","journal-title":"J Infect"},{"key":"key-10.3201\/eid2701.201178-202012202036-R24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"key-10.3201\/eid2701.201178-202012202036-R25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jpeds.2019.07.057","article-title":"Diversity of serotype replacement after pneumococcal conjugate vaccine implementation in Europe.","volume":"213","author":"Levy","year":"2019","journal-title":"J Pediatr"},{"key":"key-10.3201\/eid2701.201178-202012202036-R26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes.","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2018.12.007","article-title":"Effectiveness of 23-valent polysaccharide pneumococcal vaccine and changes in invasive pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and Wales.","volume":"6","author":"Djennad","year":"2019","journal-title":"EClinicalMedicine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3201\/eid2403.170769","article-title":"Emergence of Streptococcus pneumoniae serotype 12F after sequential introduction of 7- and 13-valent vaccines, Israel.","volume":"24","author":"Rokney","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2334-11-95","article-title":"Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination.","volume":"11","author":"Cohen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R31","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.vaccine.2017.03.031","article-title":"The herd effects of infant PCV7\/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel.","volume":"35","author":"Regev-Yochay","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2701.201178-202012202036-R34","doi-asserted-by":"publisher","first-page":"e39150","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2701.201178-202012202036-R35","doi-asserted-by":"crossref","unstructured":"Dagan R. Ben-Shimol S, Benisty R, Regev- Yochay G, Ron M, Givon-Lavi N, et al. A nationwide outbreak of invasive pneumococcal disease (IPD) caused by a novel Streptococcus pneumoniae serotype 2 (SP2) clone in the PCV13 era, in Israel. Abstract 1888. In: Abstracts of IDweek 2019; October 2\u20136, 2019; Washington, DC, USA. Alexandria (VA): Infectious Diseases Society of America; 2019.","DOI":"10.1093\/ofid\/ofz359.118"},{"key":"key-10.3201\/eid2701.201178-202012202036-R36","doi-asserted-by":"publisher","first-page":"e02579","DOI":"10.1128\/AAC.02579-18","article-title":"Whole-genome sequencing analysis of multidrug-resistant serotype 15A Streptococcus pneumoniae in Japan and the emergence of a highly resistant serotype 15A-ST9084 clone.","volume":"63","author":"Nakano","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2701.201178-202012202036-R37","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1016\/j.vaccine.2019.07.056","article-title":"Direct effect of the 13-valent pneumococcal conjugate vaccine use on pneumococcal colonization among children in Brazil.","volume":"37","author":"Neves","year":"2019","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2701.201178-202012202036-R38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12887-019-1690-5","article-title":"Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine.","volume":"19","author":"Dayie","year":"2019","journal-title":"BMC Pediatr"},{"key":"key-10.3201\/eid2701.201178-202012202036-R39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/21645515.2015.1116654","article-title":"The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.","volume":"12","author":"Cohen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2701.201178-202012202036-R40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/cid\/ciw067","article-title":"Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine.","volume":"62","author":"Tomczyk","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/1\/20-1178_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:48:42Z","timestamp":1732988922000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/1\/20-1178_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2701.201178","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}